{
    "id": "professional_medicine-080",
    "question": "A previously healthy 37-year-old woman comes to the physician because of a 3-month history of episodes of severe anxiety, shortness of breath, palpitations, and numbness in her hands and feet. Her vital signs are within normal limits. Physical examination shows no abnormalities. Thyroid function studies and an ECG show no abnormalities. Which of the following is the most appropriate pharmacotherapy?",
    "options": {
        "A": "Lithium carbonate",
        "B": "Methylphenidate",
        "C": "Olanzapine",
        "D": "Paroxetine"
    },
    "answer": "D",
    "predict": "{\"step_by_step_thinking\": \"To approach this question, we need to consider the patient's symptoms and the potential underlying causes. The patient presents with severe anxiety, shortness of breath, palpitations, and numbness in her hands and feet. These symptoms can be indicative of several conditions, including anxiety disorders, cardiovascular issues, or neurological problems. However, given the lack of abnormalities in thyroid function studies and ECG, we can rule out thyroid disorders and cardiac arrhythmias as the primary cause. The patient's symptoms of anxiety, shortness of breath, and palpitations can also be indicative of a panic disorder or generalized anxiety disorder. In this case, the numbness in her hands and feet could be related to the anxiety-induced vasoconstriction or a manifestation of a more complex condition such as fibromyalgia or a neuropathy. Considering the pharmacotherapy options provided, we need to evaluate each medication's primary indication and potential side effects. A. Lithium carbonate is primarily used to treat bipolar disorder and major depressive disorder. It is not the first-line treatment for anxiety disorders. B. Methylphenidate is primarily used to treat attention deficit hyperactivity disorder (ADHD) and narcolepsy. It is not typically used to treat anxiety disorders. C. Olanzapine is an atypical antipsychotic used to treat schizophrenia and bipolar disorder. While it can be used off-label for anxiety disorders, it is not the first-line treatment. D. Paroxetine is a selective serotonin reuptake inhibitor (SSRI) commonly used to treat depression, anxiety disorders, and obsessive-compulsive disorder. SSRIs are often considered a first-line treatment for anxiety disorders, including panic disorder and generalized anxiety disorder. Based on the patient's symptoms and the potential underlying causes, the most appropriate pharmacotherapy would be Paroxetine, as it is a commonly used SSRI for anxiety disorders and has a relatively favorable side effect profile for this patient's symptoms.\"} {\"answer_choice\": \"D\"}",
    "snippets": [],
    "scores": [],
    "execution_time": 45.770949602127075
}